Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia

Shogo Kumagai (Kurashiki, Japan), Shogo Kumagai, Tadashi Ishida, Hiromasa Tachibana, Yuhei Ito, Akihiro Ito, Toru Hashimoto

Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shogo Kumagai (Kurashiki, Japan), Shogo Kumagai, Tadashi Ishida, Hiromasa Tachibana, Yuhei Ito, Akihiro Ito, Toru Hashimoto. Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia. Eur Respir J 2015; 46: Suppl. 59, 1842

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Bacteremia in non-HIV community acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



Community adquired legionella pneumophila pneumonia in elderly patients
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014


Epidemiological features of hospital-acquired pneumonia in a neurosurgical center in Ukraine
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007

Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014